Capital International LTD Vertex Pharmaceuticals Inc Transaction History
Capital International LTD
- $2.09 Billion
- Q2 2024
A detailed history of Capital International LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital International LTD holds 100,471 shares of VRTX stock, worth $47.1 Million. This represents 2.25% of its overall portfolio holdings.
Number of Shares
100,471
Previous 99,556
0.92%
Holding current value
$47.1 Million
Previous $41.6 Million
13.16%
% of portfolio
2.25%
Previous 2.08%
Shares
21 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.5 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.99 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.49 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...